Related Experiment Video

Updated: Mar 8, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Mitochondria targeting nano agents in cancer therapeutics

Xiao-Ying Zhang1, Pei-Ying Zhang2

  • 1Nanjing University of Chinese Medicine, Information Institute, Nanjing, Jiangsu 221009, P.R. China.

Oncology Letters
|January 21, 2017
PubMed

Insights

Mitochondria-targeting nanoagents show promise in cancer therapy by delivering drugs to cellular powerhouses. Carbon nanotubes are particularly effective drug carriers, but clinical application requires further development.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Mitochondrial dysfunction is implicated in various diseases, notably cancer, making them a key therapeutic target.
  • Nanomaterials offer novel strategies for targeted drug delivery, enhancing therapeutic efficacy.
  • Carbon nanotubes (CNTs) possess unique properties suitable for drug delivery applications.

Purpose of the Study:

  • To review current mitochondria-targeting anticancer therapeutics.
  • To explore the potential of nanoagents, particularly carbon nanotubes, in cancer treatment.
  • To assess the clinical applicability of these advanced therapeutic strategies.

Main Methods:

  • A comprehensive literature search was conducted using electronic databases (MEDLINE, EMBASE, PubMed).
  • Studies focusing on mitochondria-targeting nanoagents and their role in cancer therapeutics were analyzed.
  • The review synthesized findings on nanocarrier capabilities and the specific attributes of carbon nanotubes.

Main Results:

  • Mitochondria-targeting nanoagents demonstrate significant potential in anticancer research.
  • Nanocarriers effectively deliver mitochondria-acting compounds to target sites.
  • Carbon nanotubes exhibit favorable characteristics for drug delivery, including enhanced cellular uptake and molecule conjugation.

Conclusions:

  • Mitochondria-targeting nanoagents represent a promising frontier in cancer therapeutics.
  • Carbon nanotubes are emerging as valuable tools for developing targeted anticancer drugs.
  • Further advancements are necessary to establish these therapies as clinical standards.
Keywords:
cancermitochondriananomedicine

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

830
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.8K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
59
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K